The adventitia has been recognized to play important roles in vascular oxidative stress, remodeling, and contraction. We recently demonstrated that adventitial fibroblasts are able to express endothelin (ET)-1 in response to ANG II. However, it is unclear whether ET-1 receptors are expressed in the adventitia. We therefore investigated the expression and roles of both ETA and ETB receptors in collagen synthesis and ET-1 clearance in adventitial fibroblasts. Adventitial fibroblasts were isolated and cultured from the mouse thoracic aorta by the explant method. Cultured cells were treated with ANG II (100 nmol/l) or ET-1 (10 pM) in the presence or absence of the ANG II type 1 receptor antagonist losartan (100 M), the ET-1 receptor antagonists BQ-123 (ET A receptor, 1 M) and BQ-788 (ET B receptor, 1 M), and the ETB receptor agonist sarafotoxin 6C (100 nM). ET-1 peptide levels were determined by ELISA, whereas ET A, ETB, and collagen levels were determined by Western blot analysis. ANG II increased ET-1 peptide levels in a timedependent manner. ANG II increased ET A and ETB receptor protein levels as well as collagen in a similar fashion. ANG II-induced collagen was reduced while in the presence of BQ-123, suggesting a role for the ET A receptor in the regulation of the extracellular matrix. ANG II treatment in the presence of BQ-788 significantly increased ET-1 peptide levels. Conversely, the ET B receptor agonist sarafotoxin 6C significantly decreased ET-1 peptide levels. These data implicate a role for the ET B receptor in the clearance of the ET-1 peptide. In conclusion, both ET A and ETB receptors are expressed in adventitial fibroblasts, which paves the ground for the biological significance of adventitial ET-1. The ET A receptor subtype mediates collagen I expression, whereas the ET B receptor subtype may play a protective role through increasing the clearance of the ET-1 peptide. adventia; endothelin-1; endothelin type A receptor; endothelin type B receptor THE ROLE OF ANG II in the development of hypertension and atherosclerosis has been well accepted. It has been demonstrated that endothelin (ET)-1 can contribute to many ANG II-mediated responses (8).The vascular effects of ET-1 are mediated through both ET A and ET B receptor subtypes. Specifically, the ET A receptor, located on vascular smooth muscle cells (VSMCs), has been shown to mediate vasoconstriction, the formation of ROS (21), and collagen accumulation (11). The role of the ET B receptor is associated with nitric oxide (NO)-mediated vasodilation in endothelial cells (ECs) (14) and vasoconstriction in VSMCs (36). Moreover, a report (12) has also suggest that the ET B receptor is responsible for the clearance of ET-1, a mechanism thought to keep ET-1 peptide levels low.Recent evidence has suggested that the adventitia of the blood vessel is a dynamic tissue (13). The adventitia has been identified as a major producer of ROS (38), reacting to vasoactive hormones such as ANG II (29). Moreover, local production of ET-1 within the adventitia has been r...